Salveen Richter
Stock Analyst at Goldman Sachs
(2.27)
# 2,612
Out of 4,876 analysts
202
Total ratings
40.87%
Success rate
-2.43%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Downgrades: Neutral | $29 | $17.30 | +67.68% | 5 | Jun 17, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $21.24 | +74.20% | 1 | Jun 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $51 → $44 | $4.06 | +983.74% | 4 | May 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $46.81 | +0.41% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $8.45 | +53.85% | 3 | May 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $54.72 | +90.06% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $20.95 | +95.70% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $5.86 | +53.71% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $12.04 | -16.94% | 11 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $917 → $804 | $523.24 | +53.66% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $127.35 | +54.69% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $18.05 | +77.29% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.35 | +437.31% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $110.10 | -12.81% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $27.29 | +86.88% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.39 | +177.97% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $9.70 | +23.78% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $14.19 | +40.99% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $69.61 | +0.56% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $320.84 | +15.32% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $36.59 | +107.74% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $39.73 | -6.87% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $9.28 | +18.60% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $34.09 | +55.49% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $280.19 | +24.92% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $444.82 | +25.67% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $13.01 | -61.55% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.20 | +2,494.14% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $309.65 | -27.34% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $2.54 | +766.14% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.96 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.30 | +597.67% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $5.16 | +74.59% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.44 | +22.95% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $22.07 | -45.63% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.87 | +109.06% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $56.72 | -24.19% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.45 | +37.93% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $8.06 | +1,140.69% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.35 | +8,385.36% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $95.79 | -47.80% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $15.96 | +182.04% | 1 | Mar 17, 2020 |
Sarepta Therapeutics
Jun 17, 2025
Downgrades: Neutral
Price Target: $29
Current: $17.30
Upside: +67.68%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $21.24
Upside: +74.20%
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $4.06
Upside: +983.74%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $46.81
Upside: +0.41%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $8.45
Upside: +53.85%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $54.72
Upside: +90.06%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $20.95
Upside: +95.70%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.86
Upside: +53.71%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $12.04
Upside: -16.94%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $523.24
Upside: +53.66%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $127.35
Upside: +54.69%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $18.05
Upside: +77.29%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.35
Upside: +437.31%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $110.10
Upside: -12.81%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $27.29
Upside: +86.88%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.39
Upside: +177.97%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $9.70
Upside: +23.78%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $14.19
Upside: +40.99%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $69.61
Upside: +0.56%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $320.84
Upside: +15.32%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $36.59
Upside: +107.74%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $39.73
Upside: -6.87%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $9.28
Upside: +18.60%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $34.09
Upside: +55.49%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $280.19
Upside: +24.92%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $444.82
Upside: +25.67%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $13.01
Upside: -61.55%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.20
Upside: +2,494.14%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $309.65
Upside: -27.34%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $2.54
Upside: +766.14%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $8.96
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.30
Upside: +597.67%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $5.16
Upside: +74.59%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.44
Upside: +22.95%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $22.07
Upside: -45.63%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $2.87
Upside: +109.06%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $56.72
Upside: -24.19%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.45
Upside: +37.93%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $8.06
Upside: +1,140.69%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.35
Upside: +8,385.36%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $95.79
Upside: -47.80%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $15.96
Upside: +182.04%